View in EDS HTML Full Text PDF Full Text

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.

Saved in:
Bibliographic Details
Title: Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Authors: Omer N; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel., Giladi N; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Gurevich T; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Bar-Shira A; Genetic Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel., Gana-Weisz M; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Glinka T; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Goldstein O; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Kestenbaum M; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Neurology Department, Meir Medical Center, Kfar-Saba, Israel., Cedarbaum JM; Biogen Inc., Cambridge, Massachusetts, USA.; Coeruleus Clinical Sciences LLC, Woodbridge, Connecticut, USA., Mabrouk OS; Biogen Inc., Cambridge, Massachusetts, USA., Fraser KB; Biogen Inc., Cambridge, Massachusetts, USA., Shirvan JC; Biogen Inc., Cambridge, Massachusetts, USA., Orr-Urtreger A; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Mirelman A; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Thaler A; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.
Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Jan; Vol. 37 (1), pp. 190-195. Date of Electronic Publication: 2021 Sep 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34550621
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Omer+N%22">Omer N</searchLink>; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Giladi+N%22">Giladi N</searchLink>; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Gurevich+T%22">Gurevich T</searchLink>; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Bar-Shira+A%22">Bar-Shira A</searchLink>; Genetic Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Gana-Weisz+M%22">Gana-Weisz M</searchLink>; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Glinka+T%22">Glinka T</searchLink>; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Goldstein+O%22">Goldstein O</searchLink>; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Kestenbaum+M%22">Kestenbaum M</searchLink>; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Neurology Department, Meir Medical Center, Kfar-Saba, Israel.<br /><searchLink fieldCode="AU" term="%22Cedarbaum+JM%22">Cedarbaum JM</searchLink>; Biogen Inc., Cambridge, Massachusetts, USA.; Coeruleus Clinical Sciences LLC, Woodbridge, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mabrouk+OS%22">Mabrouk OS</searchLink>; Biogen Inc., Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Fraser+KB%22">Fraser KB</searchLink>; Biogen Inc., Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Shirvan+JC%22">Shirvan JC</searchLink>; Biogen Inc., Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Orr-Urtreger+A%22">Orr-Urtreger A</searchLink>; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Mirelman+A%22">Mirelman A</searchLink>; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Thaler+A%22">Thaler A</searchLink>; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228610688%22">Movement disorders : official journal of the Movement Disorder Society</searchLink> [Mov Disord] 2022 Jan; Vol. 37 (1), pp. 190-195. <i>Date of Electronic Publication: </i>2021 Sep 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8610688 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1531-8257 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208853185%22">08853185 </searchLink><i>NLM ISO Abbreviation: </i>Mov Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34550621
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/mds.28792
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 190
    Titles:
      – TitleFull: Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Omer N
      – PersonEntity:
          Name:
            NameFull: Giladi N
      – PersonEntity:
          Name:
            NameFull: Gurevich T
      – PersonEntity:
          Name:
            NameFull: Bar-Shira A
      – PersonEntity:
          Name:
            NameFull: Gana-Weisz M
      – PersonEntity:
          Name:
            NameFull: Glinka T
      – PersonEntity:
          Name:
            NameFull: Goldstein O
      – PersonEntity:
          Name:
            NameFull: Kestenbaum M
      – PersonEntity:
          Name:
            NameFull: Cedarbaum JM
      – PersonEntity:
          Name:
            NameFull: Mabrouk OS
      – PersonEntity:
          Name:
            NameFull: Fraser KB
      – PersonEntity:
          Name:
            NameFull: Shirvan JC
      – PersonEntity:
          Name:
            NameFull: Orr-Urtreger A
      – PersonEntity:
          Name:
            NameFull: Mirelman A
      – PersonEntity:
          Name:
            NameFull: Thaler A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1531-8257
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Movement disorders : official journal of the Movement Disorder Society
              Type: main
ResultId 1